Improving Health, Gene by Gene.
HPV & STD Detection
Phronetik's HPV and STD Screening program is at the forefront of public health efforts to diagnose and manage sexually transmitted diseases (STDs), including the human papillomavirus (HPV), with precision and sensitivity. Utilizing advanced Next-Generation Sequencing (NGS) technology, our screening services offer highly accurate detection and typing of HPV and other STDs, providing critical information for effective treatment and prevention strategies.
At Phronetik, we recognize the sensitive nature of testing for Human Papillomavirus (HPV) and Sexually Transmitted Diseases (STDs). Ensuring the privacy and security of our clients' personal and health information is paramount.
​
Compliance with Regulations
Phronetik strictly adheres to all applicable health privacy laws, including the Health Insurance Portability and Accountability Act (HIPAA) and relevant international data protection regulations. Our practices are aligned with the rigorous requirements of clinical laboratory accreditation bodies, ensuring compliance with privacy and security standards.
​
HPV Screening
Our NGS-based HPV screening can differentiate between various HPV strains, distinguishing between high-risk types associated with cervical, anal, and oropharyngeal cancers, and low-risk types that cause genital warts. This detailed typing is crucial for assessing cancer risk and guiding follow-up care.
STD Screening
Supporting Public Health and Individual Well-being
Preventive Health - Early detection and treatment of HPV and STDs play a crucial role in preventing serious health complications, such as infertility, ectopic pregnancies, and cancer, thereby supporting both individual well-being and public health.
